17.00 - 19.00 hrs Wednesday 4 May 2022

*****Registration for this event is now closed, if you would like to attend please email laura@onenucleus.com*****

Digitalisation is the use of digital technologies to improve efficiency, efficacy and competitiveness, so how can life science make the most of it? With a complexification of technology inputs, the increasing amount of data generated and still long costly development cycles, digitalisation has the potential to disturb life science R&D for better outcomes. From data generation to analytics, automation to cybersecurity, there are many opportunities for life science organisations that this BioWednesday will discuss in order to lead the way to the bio-digital revolution.

Programme

17.00 - 
Arrival and registration for those attending in person

17.15 - Live stream starts

Panel
Barbara Fleck, Partner, Appleyard Lees LLP (Moderator)
Sven Sewitz, Director of Biodata Innovation, Eagle Genomics
Karim Chine, Founder, RosettaHUB
Anusha Foy, Associate Partner, KPMG
David Allan, Managing Director and Chief Technology Officer, CYSIAM Ltd

18.15 -  In-person networking at each hub

19.00 -  Close

Decentralised Hubs

There will be two ways of attending this event.

For this event we are adopting a decentralised approach where registered attendees can elect to engage in the live and interactive streamed panel discussion by joining individually online or with others at one of the physical hubs and network in-person following the panel discussion.

Sign up now and we will be in touch with you post registration to confirm your preference for attendance between:

Online
Queen Mary Enterprise Zone (London)

Prices

One Nucleus members: Free

Non-Members: £50 + VAT

Academics: please contact alicia@onenucleus.com

 

 

When
May 4th, 2022 from  5:00 PM to  7:00 PM
Location
ONLINE - webinar details will be sent to all delegates closer to the date of the event
Cambridge, Cambridgeshire
United Kingdom
Contact
Phone: 01223 896450
Phone: 01223 896456